se of treatment with low power laser in canker sores and skin burns caused by radiation therapy in patients with head and neck cancer
Not Applicable
Recruiting
- Conditions
- Radiodermatitis. Stomatitis.C07.465.864
- Registration Number
- RBR-67hjmn
- Lead Sponsor
- nivesrsidade Estadual de Montes Claros
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Individuals with a confirmed histopathologic diagnosis Squamous cell carcinoma of head and neck; 2) Individuals should have at least 20 years old; Need of radiotherapy treatmentd; Agreement to participate in the study, signed the consent form.
Exclusion Criteria
Individuals who are not able or have limitations that prevent them from responding to questionnaires.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is pain reduction in the patient after treatment. To assess the patient's pain will be used multidimensional scale for assessing pain. To determine whether there was a reduction of pain is compared to the number of sessions required to reduce pain between groups. It is important to point out that the statistical test that is best suited for this assessment can only be set after data collection.;The secondary endpoint is the reduction in the use of painkillers. To evaluate the reduction in analgesic use will be evaluated prescriptions during treatment. To determine whether there was a reduction in the use of analgesics are compared the number of sessions in use of analgesics.
- Secondary Outcome Measures
Name Time Method The laser reduces pain and improves the quality of life of the patient with head and neck cancer. Measured by comparing the WHOQOL between the case group (red and infrared laser) and control group (red laser only).
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie low-level laser therapy's effects on radiation-induced mucositis and radiodermatitis in head and neck cancer patients?
How does low-level laser therapy compare to standard-of-care treatments for managing radiation-induced oral complications in oncology?
Are there specific biomarkers that predict response to low-level laser therapy in head and neck cancer patients undergoing radiation therapy?
What are the potential adverse events associated with low-level laser therapy for radiodermatitis and stomatitis, and how can they be managed?
What combination approaches or alternative therapies have shown efficacy in treating radiation-induced mucositis and radiodermatitis alongside low-level laser therapy?